0001478242-20-000058.txt : 20200805 0001478242-20-000058.hdr.sgml : 20200805 20200805170252 ACCESSION NUMBER: 0001478242-20-000058 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200803 FILED AS OF DATE: 20200805 DATE AS OF CHANGE: 20200805 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bruehlman Ronald E CENTRAL INDEX KEY: 0001604076 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35907 FILM NUMBER: 201078434 MAIL ADDRESS: STREET 1: C/O IMS HEALTH HOLDINGS, INC. STREET 2: 83 WOOSTER HEIGHTS ROAD CITY: DANBURY STATE: CT ZIP: 06810 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IQVIA HOLDINGS INC. CENTRAL INDEX KEY: 0001478242 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 271341991 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4820 EMPEROR BLVD. CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-998-2000 MAIL ADDRESS: STREET 1: 4820 EMPEROR BLVD. CITY: DURHAM STATE: NC ZIP: 27703 FORMER COMPANY: FORMER CONFORMED NAME: Quintiles IMS Holdings, Inc. DATE OF NAME CHANGE: 20161003 FORMER COMPANY: FORMER CONFORMED NAME: Quintiles Transnational Holdings Inc. DATE OF NAME CHANGE: 20091208 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2020-08-03 0001478242 IQVIA HOLDINGS INC. IQV 0001604076 Bruehlman Ronald E C/O IQVIA HOLDINGS INC. 83 WOOSTER HEIGHTS ROAD DANBURY CT 06810 0 1 0 0 See Remarks Common Stock 2020-08-03 4 A 0 16751 0 A 16751 D Common Stock 2020-08-04 4 P 0 10000 159.94 A 26751 D Represents a grant of restricted stock units that will vest in three annual installments beginning on August 3, 2021. The price reported in Column 4 is a weighted average price for shares purchased in multiple transactions. The purchase prices range from $159.75 to $160.04 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. EVP & interim Chief Financial Officer /s/ Matthew Gilmartin, Attorney-in-Fact for Ronald E Bruehlman 2020-08-05